Advertisement

Immune Stimulation by Oligonucleotides

  • A. M. Krieg
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 131)

Abstract

As has been pointed out previously ([Stein and Cheng 1993]), DNA is a polyanion. Like other polyanions, DNA can have a broad range of biologic effects. Native or modified DNA backbones can cause immune activation which is concentration-and length-dependent and sequence-independent. However, the different backbones currently under development for antisense applications differ greatly in the degree to which they induce immune effects. As might be expected, neutral backbones have minimal, if any, immune effects (A.M. Krieg, unpublished observation). Among the charged backbones that have been carefully investigated, the greatest magnitude of nonspecific effects are seen with phosphorothioate oligodeoxynucleotides (PS-ODNs) ([Stein and Cheng 1993]).

Keywords

Immune Stimulation Immune Effect Severe Combine Immunodeficiency Disease Phosphorothioate Oligodeoxynucleotides Natural Killer Lytic Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agrawal S (1996) Antisense oligonucleotides: towards clinical trials. TIB Tech 14:376–387Google Scholar
  2. Ballas ZK, Rasmussen WL, Krieg AM (1996) Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 157:1840–1845PubMedGoogle Scholar
  3. Bird AP (1987) CpG islands as gene markers in the vertebrate nucleus. Trends Genet 3:342–347CrossRefGoogle Scholar
  4. Boggs RT, McGraw K, Condon T, Flournoy S, Villiet P, Bennett CF, Monia BP (1997) Characterization and modulation of immune stimulation by modified oligonucleotides. Antisense Nucleic Acid Drug Dev 7:461–472PubMedCrossRefGoogle Scholar
  5. Branda RF, Moore AL, Mathews L, McCormack JJ, Zon G (1993) B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1. Biochem Pharmacol 45:2037–2043PubMedCrossRefGoogle Scholar
  6. Branda RF, Moore AL, Lafayette AR, Mathews L, Hong R, Zon G, Brown T, McCormack JJ (1996a) Amplification of antibody production by phosphorothioate oligodeoxynucleotides. J Lab Clin Med 128:329–338CrossRefGoogle Scholar
  7. Branda RF, Moore AL, Hong R, McCormack JJ, Zon G, Cunningham-Rundles C (1996b) B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1. Clin Immunol Immunopathol 79:115–121CrossRefGoogle Scholar
  8. Cowdery JS, Chace JH, Krieg AM (1996) Bacterial DNA induces in vivo interferon-y production by NK cells and increases sensitivity to endotoxin. J Immunol 156:4570PubMedGoogle Scholar
  9. Crooke RM, Crooke ST, Graham MJ, Cooke ME (1996) Effect of antisense oligonucleotides on cytokine release from human keratinocytes in an in vitro model of skin. Toxicol Appl Pharmacol 140:85–93PubMedCrossRefGoogle Scholar
  10. DeFranco AL (1987) Molecular aspects of B-lymphocyte activation. Annu Rev Cell Biol 3:143PubMedCrossRefGoogle Scholar
  11. Ewel CH, Urba SJ, Kopp WC, Smith JW II, Steis RG, Rossio JL, Longo DL, Jones MJ, Alvord WG, Pinsky CM, Beveridge JM, McNitt KL, Creekmore SP (1992) Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects. Cancer Res 52:3005–3010PubMedGoogle Scholar
  12. Halpern HD, Pisetsky DS (1995) In vitro inhibition of murine IFN-y production by phosphorothioate deoxyguanosine oligomers. Immunopharmacology 29:47–52PubMedCrossRefGoogle Scholar
  13. Halpern MD, Kurlander RJ, Pisetsky DS (1996) Bacterial DNA induces murine interferon-g production by stimulation of interleukin-12 and tumor necrosis factor-a. Cell Immunol 167:72–78PubMedCrossRefGoogle Scholar
  14. Hartmann G, Krug A, Waller-Fontaine K, Endres S (1996) Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin. Mol Med 2:429–438PubMedGoogle Scholar
  15. Henry S, Monteith D, Levin AA (1997a) Antisense oligonucleotide inhibitors for the treatment of cancer. 2. Toxicologic properties of phosphorothioate oligodeoxynucleotides. Anticancer Drug Des 12:395–408Google Scholar
  16. Henry SP, Monteith D, Bennett F, Levin AA (1997b) Toxicologic and pharmacokinetic properties of chemically modified antisense oligonucleotide inhibitors of PKC-a and C-raf kinase. Anticancer Drug Des 12:409–420Google Scholar
  17. Hertl M, Neckers LM, Katz SI (1995) Inhibition of interferon-y-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consequence of antisense-specific and antisense-non-specific effects. J Invest Dermatol 104:813–818PubMedCrossRefGoogle Scholar
  18. Jakway JP, Unsinger WR, Gold MR, Mishell RI, DeFranco AL (1986) Growth regulation of the B lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products. J Immunol 137:2225–2231PubMedGoogle Scholar
  19. Karlin S, Doerfier W, Cardon LR (1994a) Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J Virol 68:2889–2897Google Scholar
  20. Karlin S, Ladunga I, Blaisdell BE (1994b) Heterogeneity of genomes: measures and values. Proc Natl Acad Sci U S A 91:12837–12841CrossRefGoogle Scholar
  21. Kimura Y, Sonehara K, Kuramoto E, Makino T, Yamamoto S, Yamamoto T, Kataoka T, Tokunaga T (1994) Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. J Biochem 116:991–994PubMedGoogle Scholar
  22. Klinman D, Yi A-K, Beaucage SL, Conover J, Krieg AM (1996) CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFN. Proc Natl Acad Sci U S A 93:2879–2883PubMedCrossRefGoogle Scholar
  23. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernage R, Bluethmann H, Kohler G (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339–342PubMedCrossRefGoogle Scholar
  24. Krieg AM, Gause WC, Gourley MF, Steinberg AD (1989) A role for endogenous retroviral sequences in the regulation of lymphocyte activation. J Immunol 143:2448–2451PubMedGoogle Scholar
  25. Krieg A, Tonkinson J, Matson S, Zhao Q, Saxon M, Zhang L-M, Bhanja U, Yakubov L, Stein CA (1993) Modification of antisense phosphodiester oligodeoxynucleotides by a 5’ cholesteryl moiety increases cellular association and improves efficacy. Proc Natl Acad Sci U S A 90:1048–1052PubMedCrossRefGoogle Scholar
  26. Krieg AK, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky G, Klinman D (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546–549PubMedCrossRefGoogle Scholar
  27. Krieg AM (1995) CpG DNA: a pathogenic factor in systemic lupus erythematosus? J Clin Immunol 15:284–292PubMedCrossRefGoogle Scholar
  28. Krieg AM (1997) Leukocyte stimulation by oligonucleotides. In: Stein C, Krieg AM (eds) Applied antisense oligonucleotide technology. Wiley, New York (in press)Google Scholar
  29. Krown SE (1986) Interferons and interferon inducers in cancer treatment. Semin Oncol 13:207–217PubMedGoogle Scholar
  30. Kuramoto E, Yano O, Kimura Y, Baba M, Makino T, Yamamoto S, Yamamoto T, Kataoka T, Tokunaga T (1992) Oligonucleotide sequences required for natural killer cell activation. Jpn J Cancer Res 83:1128–1131PubMedCrossRefGoogle Scholar
  31. Lee PP, Ramanathan M, Hunt CA, Garovoy MR (1996) An oligonucleotide blocks interferon-ysignal transduction. Transplantation 62:1297–1301PubMedCrossRefGoogle Scholar
  32. Liang H, Nishioka Y, Reich CF, Pisetsky DS, Lipsky PE (1996) Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest 98:1119–1129PubMedCrossRefGoogle Scholar
  33. Matson S, Krieg AM (1992) Nonspecific suppression of 3H-thymidine incorporation by “control” oligonucleotides. Antisense Res Dev 2:325–330PubMedGoogle Scholar
  34. McIntyre KW, Lombard-Gillooly K, Perez JR, Kunsch C, Sarmiento UM, Larigan JD, Landreth KT, Narayanan R (1993) A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-KB p65 causes sequence-specific immune stimulation. Antisense Res Dev 3:309–322PubMedGoogle Scholar
  35. Messina JP, Gilkeson GS, Pisetsky DS (1991) Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol 147:1759–1764PubMedGoogle Scholar
  36. Messina JP, Gilkeson GS, Pisetsky DS (1993) The influence of DNA structure on the in vitro synthetic polynucleotide antigens. Cell Immunol 147:148–157PubMedCrossRefGoogle Scholar
  37. Mojcik C, Gourley MF, Klinman DM, Krieg AM, Gmelig-Meyling F, Steinberg AD (1993) Administration of a phosphorothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific manner. Clin Immunol Immunopathol 67:130–136PubMedCrossRefGoogle Scholar
  38. Nossal GJ, Pike BL, Battye FL (1979) Mechanisms of clonal abortion tolerogenesis. II. Clonal behavior of immature B cells following exposure to anti-mu chain antibody. Immunology 37:203–215PubMedGoogle Scholar
  39. Perez JR, Li Y, Stein CA, Majumder S, Van Oorschot A, Narayanan R (1994) Sequence-independent induction of Spl transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci U S A 91:5957–5961PubMedCrossRefGoogle Scholar
  40. Pisetsky DS, Reich CF (1993) Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus. Life Sci 54:101–107CrossRefGoogle Scholar
  41. Ramanathan M, Lantz M, MacGregor RD, Garovoy MR, Hunt CA (1994a) Characterization of the oligodeoxynucleotide-mediated inhibition of interferon-y-induced major histocompatibility complex class I and intercellular adhesion molecule-1. J Biol Chem 269:24564–24574Google Scholar
  42. Ramanathan M, Lantz M, MacGregor RD, Huey B, Tam S, Ki Y, Garovoy MR, Hunt CA (1994b) Inhibition of interferon-y-induced major histocompatibility complex class I expression by certain oligodeoxynucleotides. Transplantation 57:612–615Google Scholar
  43. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen MD, Silverman GJ, Lotz M, Carson DA, Raz E (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352–354.PubMedCrossRefGoogle Scholar
  44. Smetsers TFCM, Boezeman JBM, Mensink EJBM (1996) Bias in nucleotide composition of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev 6:63–67PubMedCrossRefGoogle Scholar
  45. Stacey KJ, Sweet MJ, Hume DA (1996) Macrophages ingest and are activated by bacterial DNA. J Immunol 157:2116–2122PubMedGoogle Scholar
  46. Stein CA, Cheng Y-C (1993) Antisense oligonucleotides as therapeutic agents — is the bullet really magical? Science 261:1004–1012PubMedCrossRefGoogle Scholar
  47. Talmadge JE, Adams J, Phillips H, Collins M, Lenz B, Schneider M, Schlick E, Ruffmann R, Wiltrout RH, Chirogos MA (1985) Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose. Cancer Res 45:1058–1065PubMedGoogle Scholar
  48. Tanaka T, Chu CC, Paul WE (1992) An antisense oligonucleotide complementary to a sequence in Ic2b increases c2b germline transcripts, stimulates B cell DNA synthesis, and inhibits immunoglobulin secretion. J Exp Med 175:597–607PubMedCrossRefGoogle Scholar
  49. Tokunaga T, Yamamoto H, Shimada S, Abe H, Fukuda T, Fujisawa Y, Furutani Y, Yano O, Kataoka T, Sudo T, Makiguchi N, Suganuma T (1984) Antitumor activity of deoxyribonucleic acid fraction from mycobacterium bovis GCG. I. Isolation, physicochemical characterization, and antitumor activity. JNCI 72:955–962PubMedGoogle Scholar
  50. Tokunaga T, Yamamoto S, Namba K (1988) A synthetic single-stranded DNA, poly(dG,dC), induces interferon-a/ß and -y, augments natural killer activity, and suppresses tumor growth. Jpn J Cancer Res 79:682–686PubMedCrossRefGoogle Scholar
  51. Tsubata T, Wu J, Honjo T (1993) B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 364:645–648PubMedCrossRefGoogle Scholar
  52. Waldschmidt TJ, Kroese FGM, Tygrett LT, Conrad DH, Lynch RG (1991) The expression of B cell surface receptors. III. The murine low-affinity IgE Fc receptor is not expressed on Ly 1 or “Ly 1-like” B cells. Int Immunol 3:305–315PubMedCrossRefGoogle Scholar
  53. Wiltrout RH, Salup RR, Twilley TA, Talmadge JE (1985) Immunomodulation of natural killer activity by polyribonucleotides. J Biol Respir Mod 4:512–517Google Scholar
  54. Yamamoto S, Kuramoto E, Shimada S, Tokunaga T (1988) In vitro augmentation of natural killer cell activity and production of interferon-a/ß and -y with deoxyribonucleic acid fraction from mycobacterium bovis BCG. Jpn J Cancer Res 79:866–873PubMedCrossRefGoogle Scholar
  55. Yamamoto S, Yamamoto T, Shimada S, Kuramoto E, Yano O, Kataoka T, Tokunaga T (1992a) DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 36:983–997Google Scholar
  56. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T (1992b) Unique palindromic sequences in synthetic oligonucleotides are required to induce INF and augment INF-mediated natural killer activity. J Immunol 148:4072–4076Google Scholar
  57. Yaswen P, Stampfer MR, Ghosh K, Cohen JS (1993) Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res Dev 3:67–77PubMedGoogle Scholar
  58. Yi A-K, Chace JH, Cowdery JS, Krieg AM (1996a) IFN-y promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. J Immunol 156:558–564Google Scholar
  59. Yi A-K, Hornbeck P, Lafrenz DE, Krieg AM (1996b) CpG DNA rescue of murine B lymphoma cells from anti-IgM induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-XL. J Immunol 157:4918–4925Google Scholar
  60. Yi A-K, Klinman DM, Martin TL, Matson S, Krieg AM (1996c) Rapid immune activation by CpG motifs in bacterial DNA: systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J Immunol 157:5394–5402Google Scholar
  61. Zhao Q, Song X, Waldschmidt T, Fisher E, Krieg AM (1996) Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation. Blood 88:1788–1795PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • A. M. Krieg

There are no affiliations available

Personalised recommendations